Acute inflammation induced by the biopsy of mouse mammary tumors promotes the development of metastasis

Breast Cancer Research and Treatment

Volumn 139, Issue 2, 2013, Pages 391-401

  Hobson, Julia ^a   Gummadidala, Phani ^a   Silverstrim, Brian ^a   Grier, Dore ^a   Bunn, Janice ^b   James, Ted ^c   Rincon, Mercedes ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b University of Vermont   (United States)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

Acute inflammation; Biopsy; Breast cancer; Chronic inflammation; Inflammation; LL 6; Lung; Metastases; Neutrophils; Surgery

Indexed keywords

IBUPROFEN; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RISK; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG EFFECT; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; LUNG METASTASIS; MICROMETASTASIS; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; TUMOR BIOPSY; TUMOR PROMOTION; TUMOR VOLUME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD45; BIOPSY; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; INTERLEUKIN-6; KI-67 ANTIGEN; LUNG NEOPLASMS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; TUMOR BURDEN;

EID: 84878755912     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2575-1     Document Type: Article

References (36)

1. Grange JM, Stanford JL, Stanford CA (2002) Campbell De Morgan's observations on cancer, and their relevance today. J R Soc Med 95:296-299
2. Comen EA (2012) Tracking the seed and tending the soil: evolving concepts in metastatic breast cancer. Discov Med 14:97-104
3. Psaila B, Kaplan RN, Port ER, Lyden D (2006) Priming the soil for breast cancer metastasis: the pre-metastatic niche. Breast Dis 26:65-74
4. Paget S (1889) The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev 8:98-101
5. Terzic J, Grivennikov S, Karin E, Karin M (2010) Inflammation and colon cancer. Gastroenterology 138:2101-2114 e2105
6. Ullman TA, Itzkowitz SH (2011) Intestinal inflammation and cancer. Gastroenterology 140:1807-1816
7. Roy LD, Ghosh S, Pathangey LB, Tinder TL, Gruber HE, Mukherjee P (2011) Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer. BMC Cancer 11:365
8. Roy LD, Pathangey LB, Tinder TL, Schettini JL, Gruber HE, Mukherjee P (2009) Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis. Breast Cancer Res 11:R56
9. Ruffell B, Affara NI, Coussens LM (2012) Differential macrophage programming in the tumor microenvironment. Trends Immunol 33:119-126
10. Jensen HK, Donskov F, Marcussen N, Nordsmark M, Lundbeck F, von der Maase H (2009) Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J Clin Oncol 27:4709-4717
11. Bellocq A, Antoine M, Flahault A, Philippe C, Crestani B, Bernaudin JF, Mayaud C, Milleron B, Baud L, Cadranel J (1998) Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Am J Pathol 152:83-92
12. Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T, Widmann WD (2012) Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol 19:217-224
13. Aspord C, Pedroza-Gonzalez A, Gallegos M, Tindle S, Burton EC, Su D, Marches F, Banchereau J, Palucka AK (2007) Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development. J Exp Med 204:1037-1047
14. Pedroza-Gonzalez A, Xu K, Wu TC, Aspord C, Tindle S, Marches F, Gallegos M, Burton EC, Savino D, Hori T et al (2011) Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J Exp Med 208:479-490
15. Ammirante M, Luo JL, Grivennikov S, Nedospasov S, Karin M (2010) B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 464:302-305
16. de Visser KE, Korets LV, Coussens LM (2005) De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7:411-423
17. Schioppa T, Moore R, Thompson RG, Rosser EC, Kulbe H, Nedospasov S, Mauri C, Coussens LM, Balkwill FR (2011) B regulatory cells and the tumor-promoting actions of TNF-alpha during squamous carcinogenesis. Proc Natl Acad Sci USA 108:10662-10667
18. Guy CT, Cardiff RD, Muller WJ (1992) Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12:954-961
19. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Constantini F (1994) Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13:1189-1196
20. Neveu W, Allard JB, Dienz O, Wargo MJ, Ciliberto G, Whittaker LA, Rincon M (2009) IL-6 is required for airway mucus production induced by inhaled fungal allergens. J Immunol 183:1732-1738
21. Allard JB, Poynter ME, Marr KA, Cohn L, Rincon M, Whittaker LA (2006) Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator. J Immunol 177:5186-5194
22. Rincon M, Broadwater G, Harris L, Crocker A, Weaver D, Dressler H, Berry D, Sutton L, Michaelson R, Messino M et al (2006) Interleukin-6 and multidrug resistance protein 1 (PGP-1) expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806. Breast Cancer Res Treat 100:301-308
23. Baribault H, Wilson-Heiner M, Muller W, Penner J, Bakhiet N (1997) Functional analysis of mouse keratin 8 in polyoma middle T-induced mammary gland tumours. Transgenic Res 6:359-367
24. Waldner MJ, Foersch S, Neurath MF (2012) Interleukin-6-a key regulator of colorectal cancer development. Int J Biol Sci 8:1248-1253
25. He G, Karin M (2011) NF-kappaB and STAT3 - key players in liver inflammation and cancer. Cell Res 21:159-168
26. Tawara K, Oxford JT, Jorcyk CL (2011) Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies. Cancer Manag Res 3:177-189
27. Shakhar G, Ben-Eliyahu S (2003) Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol 10:972-992
28. Coussens LM, Zitvogel L, Palucka AK (2013) Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339:286-291
29. Foekens JA, Ries C, Look MP, Gippner-Steppert C, Klijn JG, Jochum M (2003) The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer. Cancer Res 63:337-341
30. Foekens JA, Ries C, Look MP, Gippner-Steppert C, Klijn JG, Jochum M (2003) Elevated expression of polymorphonuclear leukocyte elastase in breast cancer tissue is associated with tamoxifen failure in patients with advanced disease. Br J Cancer 88:1084-1090
31. Houghton AM (2010) The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances. Cell Cycle 9:1732-1737
32. Rincon M (2012) Interleukin-6: from an inflammatory marker to a target for inflammatory diseases. Trends Immunol 33:571-577
33. Grivennikov SI, Karin M (2011) Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 70(Suppl 1):i104-i108
34. Sansone P, Bromberg J (2012) Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol 30:1005-1014
35. Rokavec M, Wu W, Luo JL (2012) IL6-mediated suppression of miR-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis. Mol Cell 45:777-789
36. Rose-John S (2012) IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int J Biol Sci 8:1237-1247